Thomas P Howard - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Thomas P Howard

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2020

Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor HomoharringtonineThomas P Howard, Elaine M Oberlick, Matthew G Rees, et al.

Cancer Research|February 14, 2019

MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsThomas P Howard, Taylor E Arnoff, Melinda R Song, et al.

Elife|March 13, 2019

Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibitionAndrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2020

Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor HomoharringtonineThomas P Howard, Elaine M Oberlick, Matthew G Rees, et al.

Cancer Research|February 14, 2019

MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsThomas P Howard, Taylor E Arnoff, Melinda R Song, et al.

Elife|March 13, 2019

Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibitionAndrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.

Pageof 5